All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy
AI Sentiment
Highly Positive
8/10
as of 02-09-2026 10:24am EST
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | GERMANTOWN |
| Market Cap: | 225.5M | IPO Year: | N/A |
| Target Price: | $25.58 | AVG Volume (30 days): | 465.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.25 - $28.00 | Next Earning Date: | 03-02-2026 |
| Revenue: | $29,298,000 | Revenue Growth: | 31.94% |
| Revenue Growth (this year): | 59.55% | Revenue Growth (next year): | 70.49% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -56166000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
SENS Breaking Stock News: Dive into SENS Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
AI Sentiment
Neutral
4/10
AI Sentiment
Highly Positive
8/10
See how SENS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SENS Senseonics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.